Bovine viral diarrhea virus (BVDV) is a major viral pathogen in cattle, leading to significant economic losses worldwide through cattle infections and contamination of biological products. BVDV, together with classical swine fever virus (CSFV) and border disease virus (BDV), is classified within the genus Pestivirus of the family Flaviviridae. BVDV poses a complex challenge due to its diverse genetic makeup, comprising two primary genotypes, BVDV-1 and BVDV-2. Each genotype is further categorized into two biotypes—cytopathic (CP) and noncytopathic (NCP)—which differ in their ability to cause cell damage in laboratory cultures. The NCP biotype is associated with persistent infections, leading to the birth of calves that continuously shed the virus, perpetuating the disease within herds. BVDV affects all ages of cattle from fetuses to adults, and can manifest in several forms, ranging from subclinical infections to severe presentations, such as mucosal disease (MD) and hemorrhagic syndrome (HS). The virus is notorious for its ability to suppress the immune system, predisposing infected animals to secondary infections and complicating disease control efforts. Transmission of BVDV occurs through direct contact with infected animals, as well as indirectly via contaminated environments, vectors, and veterinary equipment. Understanding the pathogenesis, epidemiology, and immune evasion tactics of BVDV is essential for developing effective control and prevention strategies. Persistently infected (PI) animals are the primary reservoirs of BVDV; therefore, early identification and removal of PI animals are crucial for controlling and preventing the spread of the virus. Vaccination continues to be a fundamental component of BVDV management, but its effectiveness is challenged by the genetic variability of the virus and the need for vaccines that offer broad-spectrum protection.